# Triatomic Management LP

> Institutional holdings reported to the SEC as of Q2 2024 on Form 13F. CIK 1852813. Source: https://holderbook.com/funds/1852813-triatomic-management-lp/

- Reported value: $3.4M
- Positions: 8
- Weight of the ten largest: 100.0%
- Filed: 2024-08-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| GAOTU TECHEDU INC | [GOTU](https://holderbook.com/stocks/GOTU/) | $1.1M | 234,000 | 33.8% | 5 |
| WAYFAIR INC | [W](https://holderbook.com/stocks/W/) | $791.0K | 15,000 | 23.3% | 1 |
| MODERNA INC | [MRNA](https://holderbook.com/stocks/MRNA/) | $623.4K | 5,250 | 18.4% | 1 |
| AGNT INC | [AGNT](https://holderbook.com/stocks/AGNT/) | $397.3K | 35,203 | 11.7% | 7 |
| THE ONCOLOGY INSTITUTE INC | [TOI](https://holderbook.com/stocks/TOI/) | $369.4K | 802,965 | 10.9% | 11 |
| CAREMAX INC | [CMAXQ](https://holderbook.com/stocks/CMAXQ/) | $57.5K | 20,613 | 1.7% | 2 |
| SENTI BIOSCIENCES INC | [SNTIXXXX](https://holderbook.com/stocks/SNTIXXXX/) | $4.3K | 15,493 | 0.1% | 8 |
| CAREMAX INC | [CMAXW](https://holderbook.com/stocks/CMAXW/) | $917 | 65,021 | 0.0% | 11 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2024 | -17.9% | +4.0% | -21.9% | 99% |
| Q1 2024 | -6.7% | +10.0% | -16.7% | 67% |
| Q1 2023 | +9.5% | +7.0% | +2.5% | 81% |
| Q4 2022 | -14.5% | +7.1% | -21.6% | 86% |
| Q3 2022 | -3.0% | -5.3% | +2.4% | 63% |
| Q2 2022 | -31.7% | -16.5% | -15.3% | 87% |
| Q1 2022 | -20.2% | -4.9% | -15.3% | 96% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2024 | $3.4M | 8 |
| Q1 2024 | $53.6M | 25 |
| Q4 2023 | $78.5M | 32 |
| Q3 2023 | $144.7M | 45 |
| Q2 2023 | $97.6M | 49 |
| Q1 2023 | $148.6M | 45 |
| Q4 2022 | $118.8M | 48 |
| Q3 2022 | $173.9M | 49 |
| Q2 2022 | $108.8M | 42 |
| Q1 2022 | $123.1M | 39 |
| Q4 2021 | $163.2M | 40 |